Viral Clearance Market by Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Inactivation, Removal (Precipitation), Detection (PCR, ELISA)) & End User (Pharmaceutical & Biotechnology, CROs, Research Institute) - Global Forecast to 2020

ウイルス排除の世界市場:ウイルス検出、ウイルス除去、ウイルス不活性化

◆タイトル:Viral Clearance Market by Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Inactivation, Removal (Precipitation), Detection (PCR, ELISA)) & End User (Pharmaceutical & Biotechnology, CROs, Research Institute) - Global Forecast to 2020
◆商品コード:MAM-BT-4202
◆調査・発行会社:MarketsandMarkets
◆発行日:2016年4月4日
◆ページ数:166
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、ウイルス排除の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、用途別分析、方式別分析、需要先別分析、地域別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global viral clearance market is valued at USD 285.5 Million in 2015 and is expected to grow at a CAGR of 12.3%, to reach USD 510.3 Million by 2020. Biologics are the products made from plant, animal or microorganism sources. Viral clearance is important and mandatory for biologics as these products are used for the treatment and diagnostic purposes in humans. As the disease burden in the world is increasing the demand for the medicines is increasing hence the production of biologics, injectables etc., is on a rise. Also, more and more pharmaceutical and biotechnology firms are gearing to cater to the growing demands of medicines. This aids to the growth of the market.

This report segments the global viral clearance market into method, end user, application, and geography. The method segments included in the report are viral detection method, viral removal method, and viral inactivation method. The viral detection method is further subsegmented in to plaque assays, PCR, ELISA, and other viral detection method. Other viral detection method includes western blot, transmission EM, in vivo assay, in vitro assay, and NGS (Next Generation Sequencing). The viral removal method is further subsegmented in to chromatography, nanofiltration, and precipitation. The viral inactivation method is further subsegmented in to solvent detergent method, pasteurization, and other viral inactivation method. Other viral inactivation method includes low pH, microwave heating, irradiation, and high-energy light.

Based on end user this market is categorized into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users. Other end user segment primarily includes medical device companies, cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.

The application segments included in the report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics. Based on geography the viral clearance market is segmented into North America, Europe, Asia and Rest of the World (RoW).

The high degree of market consolidation is a major factor restraining the growth of this market. The major players in the viral clearance market include Avance Biosciences Inc. (U.S.), BSL BIOSERVICE (Germany), Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Lonza Group (Switzerland), Merck & Co., Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), SGS S.A. (Switzerland), Texcell, Inc. (France), and WuXi PharmaTech (Cayman) Inc. (China).

【レポートの目次】

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions

3 Executive Summary (Page No. – 26)

4 Premium Insights (Page No. – 31)
4.1 Global Viral Clearance Market Overview
4.2 Life Cycle Analysis, By Region

5 Market Overview (Page No. – 35)
5.1 Introduction
5.1.1 Market Segmentation, By Application
5.1.2 Market Segmentation, By End User
5.1.3 Market Segmentation, By Method
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rapid Growth in Pharmaceutical and Biotechnology Industries
5.2.1.2 Increasing Number of New Drug Launches
5.2.1.3 Strong Trend of R&D Investments in the Life Sciences Industry
5.2.1.4 Increasing Government Support for Pharmaceutical and Biotechnology Industries
5.2.1.5 High Incidence and Large Economic Burden of Chronic Diseases
5.2.2 Restraints
5.2.2.1 High Degree of Consolidation to Act as A Major Barrier for New Entrants
5.2.3 Opportunities
5.2.3.1 Increasing Pharmaceutical Outsourcing
5.2.3.2 Developing Countries Present Significant Opportunities for the Viral Clearance Market
5.2.4 Challenges
5.2.4.1 Stringent Regulatory Frameworks and Time-Consuming Approval Processes

6 Viral Clearance Market, By Application (Page No. – 44)
6.1 Introduction
6.2 Vaccines and Therapeutics
6.3 Blood and Blood Products
6.4 Cellular and Gene Therapy Products
6.5 Tissue and Tissue Products
6.6 Stem Cell Products

7 Viral Clearance Market, By End User (Page No. – 54)
7.1 Introduction
7.2 Pharmaceutical and Biotechnology Companies
7.3 Contract Research Organizations
7.4 Academic Research Institutes
7.5 Other End Users

8 Viral Clearance Market, By Method (Page No. – 63)
8.1 Introduction
8.2 Viral Detection Method
8.2.1 Plaque Assays
8.2.2 Pcr
8.2.3 Elisa
8.2.4 Other Viral Detection Methods
8.3 Viral Removal
8.3.1 Chromatography
8.3.2 Nanofiltration
8.3.3 Precipitation
8.4 Viral Inactivation
8.4.1 Solvent Detergent Method
8.4.2 Pasteurization
8.4.3 Other Methods

9 Viral Clearance Market, By Region (Page No. – 86)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.4 Asia
9.5 Rest of the World

10 Competitive Landscape (Page No. – 126)
10.1 Overview
10.1.1 Strategic Overview
10.2 Leading Players in the Viral Clearance Market
10.3 Competitive Situation and Trends
10.3.1 Expansions
10.3.2 Agreements, Collaborations, and Partnerships
10.3.3 Acquisitions
10.3.4 Services Launches

11 Company Profiles (Page No. – 134)
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 Introduction
11.2 Charles River Laboratories International, Inc.
11.3 Lonza Group
11.4 Sigma-Aldrich Corporation
11.5 SGS S.A.
11.6 Wuxi Pharmatech (Cayman) Inc.
11.7 Avance Biosciences Inc.
11.8 BSL Bioservice
11.9 Clean Cells Inc.
11.10 Merck KGAA
11.11 Texcell, Inc.

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 156)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.5 Introducing RT: Real-Time Market Intelligence
12.6 Available Customizations
12.7 Related Reports

List of Tables (76 Tables)

Table 1 Viral Clearance Market Summary
Table 2 Rapid Growth in Pharmaceutical and Biotechnology Industries Driving the Growth of the Market
Table 3 High Degree of Consolidation is A Major Market Restraint
Table 4 Increasing Pharmaceutical Outsourcing to Offer Significant Growth Opportunities in the Market
Table 5 Stringent Regulatory Frameworks are A Major Market Challenge
Table 6 Market Size, By Application, 2013–2020 (USD Million)
Table 7 Market Size for Vaccines and Therapeutics, By Region, 2013–2020 (USD Million)
Table 8 Market Size for Blood and Blood Products, By Region, 2013–2020 (USD Million)
Table 9 Market Size for Cellular and Gene Therapy Products, By Region, 2013–2020 (USD Million)
Table 10 Market Size for Tissue and Tissue Products, By Region, 2013–2020 (USD Million)
Table 11 Market Size for Stem Cell Products, By Region, 2013–2020 (USD Million)
Table 12 Market Size, By End User, 2013–2020 (USD Million)
Table 13 Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2013–2020 (USD Million)
Table 14 Market Size for Contract Research Organizations, By Region, 2013–2020 (USD Million)
Table 15 Market Size for Academic Research Institutes, By Region, 2013–2020 (USD Million)
Table 16 Market Size for Other End Users, By Region, 2013–2020 (USD Million)
Table 17 Market Size, By Method, 2013–2020 (USD Million)
Table 18 Market Size for Viral Detection, By Method, 2013–2020 (USD Million)
Table 19 Market Size for Viral Detection, By Region, 2013–2020 (USD Million)
Table 20 Viral Detection Market Size for Plaque Assays, By Region, 2013–2020 (USD Million)
Table 21 Viral Detection Market Size for PCR, By Region, 2013–2020 (USD Million)
Table 22 Viral Detection Market Size for Elisa, By Region, 2013–2020 (USD Million)
Table 23 Viral Detection Market Size for Other Methods, By Region, 2013–2020 (USD Million)
Table 24 Market Size for Viral Removal, By Method, 2013–2020 (USD Million)
Table 25 Market Size for Viral Removal, By Region, 2013–2020 (USD Million)
Table 26 Viral Removal Market Size for Chromatography, By Region, 2013–2020 (USD Million)
Table 27 Viral Removal Market Size for Nanofiltration, By Region, 2013–2020 (USD Million)
Table 28 Viral Removal Market Size for Precipitation, By Region, 2013–2020 (USD Million)
Table 29 Market Size for Viral Inactivation, By Method, 2013–2020 (USD Million)
Table 30 Market Size for Viral Inactivation, By Region, 2013–2020 (USD Million)
Table 31 Viral Inactivation Market Size for Solvent Detergent Method, By Region, 2013–2020 (USD Million)
Table 32 Viral Inactivation Market Size for Pasteurization, By Region, 2013–2020 (USD Million)
Table 33 Viral Inactivation Market Size for Other Methods, By Region, 2013–2020 (USD Million)
Table 34 Market Size, By Region, 2013–2020 (USD Million)
Table 35 North America: Market Size, By Country, 2013–2020 (USD Million)
Table 36 North America: Market Size, By Application, 2013–2020 (USD Million)
Table 37 North America: Market Size, By End User, 2013–2020 (USD Million)
Table 38 North America: Market Size, By Method, 2013–2020 (USD Million)
Table 39 North America: Viral Detection Methods Market Size, By Type, 2013–2020 (USD Million)
Table 40 North America: Viral Removal Methods Market Size, By Type, 2013–2020 (USD Million)
Table 41 North America: Viral Inactivation Methods Market Size, By Type, 2013–2020 (USD Million)
Table 42 U.S.: Market Size, By Application, 2013–2020 (USD Million)
Table 43 U.S.: Market Size, By End User, 2013–2020 (USD Million)
Table 44 U.S.: Market Size, By Method, 2013–2020 (USD Million)
Table 45 U.S.: Viral Detection Methods Market Size, By Type, 2013–2020 (USD Million)
Table 46 U.S.: Viral Removal Methods Market Size, By Type, 2013–2020 (USD Million)
Table 47 U.S.: Viral Inactivation Methods Market Size, By Type, 2013–2020 (USD Million)
Table 48 Canada: Viral Clearance Market Size, By Application, 2013–2020 (USD Million)
Table 49 Canada: Viral Clearance Market Size, By End User, 2013–2020 (USD Million)
Table 50 Canada: Viral Clearance Market Size, By Method, 2013–2020 (USD Million)
Table 51 Canada: Viral Detection Methods Market Size, By Type, 2013–2020 (USD Million)
Table 52 Canada: Viral Removal Methods Market Size, By Type, 2013–2020 (USD Million)
Table 53 Canada: Viral Inactivation Methods Market Size, By Type, 2013–2020 (USD Million)
Table 54 Europe: Viral Clearance Market Size, By Application, 2013–2020 (USD Million)
Table 55 Europe: Viral Clearance Market Size, By End User, 2013–2020 (USD Million)
Table 56 Europe: Viral Clearance Market Size, By Method, 2013–2020 (USD Million)
Table 57 Europe: Viral Detection Methods Market Size, By Type, 2013–2020 (USD Million)
Table 58 Europe: Viral Removal Methods Market Size, By Type, 2013–2020 (USD Million)
Table 59 Europe: Viral Inactivation Methods Market Size, By Type, 2013–2020 (USD Million)
Table 60 Asia: Viral Clearance Market Size, By Application, 2013–2020 (USD Million)
Table 61 Asia: Viral Clearance Market Size, By End User, 2013–2020 (USD Million)
Table 62 Asia: Viral Clearance Market Size, By Method, 2013–2020 (USD Million)
Table 63 Asia: Viral Detection Methods Market Size, By Type, 2013–2020 (USD Million)
Table 64 Asia: Viral Removal Methods Market Size, By Type, 2013–2020 (USD Million)
Table 65 Asia: Viral Inactivation Methods Market Size, By Type, 2013–2020 (USD Million)
Table 66 RoW: Viral Clearance Market Size, By Application, 2013–2020 (USD Million)
Table 67 RoW: Viral Clearance Market Size, By End User, 2013–2020 (USD Million)
Table 68 RoW: Viral Clearance Market Size, By Method, 2013–2020 (USD Million)
Table 69 RoW: Viral Detection Methods Market Size, By Type, 2013–2020 (USD Million)
Table 70 RoW: Viral Removal Methods Market Size, By Type, 2013–2020 (USD Million)
Table 71 RoW: Viral Inactivation Methods Market Size, By Type, 2013–2020 (USD Million)
Table 72 Market Developments Between 2012 and 2016
Table 73 Expansions, 2012–2016
Table 74 Agreements, Collaborations, and Partnerships, 2012–2016
Table 75 Acquisitions, 2012–2016
Table 76 Services Launches, 2012–2015

List of Figures (89 Figures)

Figure 1 Global Viral Clearance Market
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Viral Clearance Market Size, By Application, 2015 vs 2020 (USD Million)
Figure 8 Viral Clearance Market Size, By End User, 2015 vs 2020 (USD Million)
Figure 9 Viral Clearance Market Size, By Method, 2015 vs 2020 (USD Million)
Figure 10 Viral Clearance Market Size, By Region, 2015 vs 2020 (USD Million)
Figure 11 Growth in the Pharmaceutical and Biotechnology Industries Will Drive the Viral Clearance Market in the Forcasted Period (2015-2020)
Figure 12 Vaccines and Therapeutics Application Segment to Account for the Largest Market Share in 2015
Figure 13 Asia to Witness the Highest Growth Rate in the Forecast Period (2015 to 2020)
Figure 14 Asia Holds Lucrative Growth Opportunities
Figure 15 Viral Clearance Market Segmentation, By Application
Figure 16 Viral Clearance Market Segmentation, By End User
Figure 17 Viral Clearance Market Segmentation, By Method
Figure 18 Viral Clearance Market: Drivers, Restraints, Opportunities, & Challenges
Figure 19 Number of New Biologics Launched, By Year, 2003–2013
Figure 20 Viral Clearance Market, By Application
Figure 21 Viral Clearance Market Size, By Application, 2015 (USD Million)
Figure 22 North America to Dominate the Vaccines and Therapeutics Application Segment in 2015
Figure 23 North America to Dominate the Blood and Blood Products Application Segment in 2015
Figure 24 Asia to Witness Highest Growth in the Cellular and Gene Therapy Products Application Segment During the Forecast Period
Figure 25 North America to Command the Largest Share of the Tissue and Tissue Products Application Segment During the Forecast Period
Figure 26 Asia to Witness Highest Growth in the Stem Cell Products Application Segment During the Forecast Period
Figure 27 Viral Clearance Market, By End User
Figure 28 Viral Clearance Market Size, By End User, 2015 (USD Million)
Figure 29 North America to Dominate the Pharmaceutical and Biotechnology Companies End-User Segment During the Forecast Period
Figure 30 Asia to Witness the Highest Growth in the Contract Research Organizations End-User Segment During the Forecast Period
Figure 31 Asia to Witness the Highest Growth in the Academic Research Institutes End-User Segment During the Forecast Period
Figure 32 North America to Dominate the Other End-Users Segment During the Forecast Period
Figure 33 Viral Clearance Market, By Method
Figure 34 Viral Clearance Market Size, By Method, 2015 (USD Million)
Figure 35 Plaque Assays to Dominate the Viral Detection Method Segment in 2015
Figure 36 North America to Dominate the Viral Detection Market in 2015
Figure 37 North America to Dominate the Plaque Assays Method Segment in 2015
Figure 38 North America to Dominate the PCR Market in 2015
Figure 39 North America to Dominate the Market for Elisa Method in 2015
Figure 40 North America to Dominate the Market for Other Viral Detection Methods in 2015
Figure 41 Chromatography to Dominate the Viral Removal Methods Segment in 2015
Figure 42 North America to Dominate the Viral Removal Market in 2015
Figure 43 North America to Dominate the Chromatography Market in 2015
Figure 44 North America to Command Largest Share in the Nanofiltration Segment in 2015
Figure 45 North America to Hold Largest Share of the Precipitation Market in 2015
Figure 46 Solvent Detergent Method to Hold Largest Share in Viral Inactivation Market in 2015
Figure 47 North America to Dominate the Viral Inactivation Market in 2015
Figure 48 North America to Dominate the Solvent Detergent Method Segment in 2015
Figure 49 North America to Dominate the Pasteurization Segment in 2015
Figure 50 North America to Dominate the Other Viral Inactivation Methods Segment in 2015
Figure 51 Viral Clearance Market Segmentation, By Region
Figure 52 North America to Dominate the Global Viral Clearance Market During the Forecast Period
Figure 53 Asian Viral Clearance Market to Witness the Highest Growth From 2015 to 2020
Figure 54 North America: Viral Clearance Market Snapshot
Figure 55 U.S. to Witness Highest Growth in the North American Viral Clearance Market
Figure 56 Vaccines and Therapeutics Segment to Command the Largest Share of the North American Viral Clearance Market
Figure 57 Pharmaceutical and Biotechnology Companies to Dominate the North American Viral Clearance Market, By End User
Figure 58 Viral Detection, the Largest Method Segment in North America in 2015
Figure 59 Plaque Assays Segment to Hold Largest Share of the North American Viral Detection Market in 2015
Figure 60 Chromatography to Form the Largest Viral Removal Method Segment in North America in 2015
Figure 61 Solvent Detergent Segment to Dominate the Viral Inactivation Market, By Method, in North America
Figure 62 Vaccines and Therapeutics Segment to Command the Largest Share of the European Viral Clearance Market
Figure 63 Pharmaceutical and Biotechnology Companies to Dominate the European Viral Clearance Market
Figure 64 Viral Detection to Dominate the Viral Clearance Methods Market in Europe in 2015
Figure 65 Plaque Assays to Form the Largest Viral Detection Method Segment in Europe in 2015
Figure 66 Chromatography to Form the Largest Viral Removal Method Segment in Europe in 2015
Figure 67 Solvent Detergent Method to Form the Largest Viral Inactivation Method Segment in Europe in 2015
Figure 68 Asia: Viral Clearance Market Snapshot
Figure 69 Vaccines and Therapeutics Segment to Command the Largest Share of the Asian Viral Clearance Market
Figure 70 Pharmaceutical and Biotechnology Companies to Dominate the Asian Viral Clearance Market
Figure 71 Viral Detection to Dominate the Viral Clearance Methods Market in Asia in 2015
Figure 72 Plaque Assays to Form the Largest Viral Detection Method Segment in Asia in 2015
Figure 73 Chromatography to Form the Largest Viral Removal Method Segment in Asia in 2015
Figure 74 Solvent Detergent Method to Form the Largest Viral Inactivation Method Segment in Asia in 2015
Figure 75 Vaccines and Therapeutics Segment to Command the Largest Share of the Viral Clearance Market in the Rest of the World Region
Figure 76 Pharmaceutical and Biotechnology Companies to Dominate the Viral Clearance Market in the Rest of the World Region
Figure 77 Viral Detection to Dominate the Viral Clearance Methods Market in the Rest of the World Region in 2015
Figure 78 Plaque Assays to Form the Largest Viral Detection Method Segment in the Rest of the World Region in 2015
Figure 79 Chromatography to Form the Largest Viral Removal Method Segment in the Rest of the World Region in 2015
Figure 80 Solvent Detergent Method to Form the Largest Viral Inactivation Method Segment in the Rest of the World Region in 2015
Figure 81 Expansions and Acquisitions—Key Strategies Adopted By Players
Figure 82 Viral Clearance Market Share Analysis, By Key Player, 2014
Figure 83 Financial Performance of Leading Market Players
Figure 84 Company Snapshot: Charles River Laboratories International, Inc.
Figure 85 Company Snapshot: Lonza Group
Figure 86 Company Snapshot: Sigma-Aldrich Corporation
Figure 87 Company Snapshot: SGS S.A.
Figure 88 Company Snapshot: Wuxi Pharmatech (Cayman) Inc.
Figure 89 Company Snapshot: Merck & Co., Inc.

【レポートのキーワード】

ウイルス排除、ウイルス検出、ウイルス除去、ウイルス不活性化、ワクチン、治療、血液、遺伝子療法、組織、幹細胞、製薬、バイオ技術、プラークアッセイ、PCR、クロマトグラフィー、ナノ濾過、パスツーリゼーション、溶剤

★調査レポート[ウイルス排除の世界市場:ウイルス検出、ウイルス除去、ウイルス不活性化] ( Viral Clearance Market by Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Inactivation, Removal (Precipitation), Detection (PCR, ELISA)) & End User (Pharmaceutical & Biotechnology, CROs, Research Institute) - Global Forecast to 2020 / MAM-BT-4202) 販売に関する免責事項
[ウイルス排除の世界市場:ウイルス検出、ウイルス除去、ウイルス不活性化] ( Viral Clearance Market by Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Inactivation, Removal (Precipitation), Detection (PCR, ELISA)) & End User (Pharmaceutical & Biotechnology, CROs, Research Institute) - Global Forecast to 2020 / MAM-BT-4202) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆